Jul 16, 2026 02:23AM
Apr 28, 2026 02:23AM
Mar 27, 2026 03:52AM
Feb 5, 2026 02:22AM
Oct 20, 2025 03:54AM
Jul 16, 2025 02:23AM
Apr 29, 2025 02:10AM Sobi publishes Q1 2025 report: Portfolio continues to deliver
Apr 1, 2025 02:43AM
Feb 5, 2025 02:20AM
Oct 24, 2024 03:24AM
Jul 16, 2024 05:17AM
Apr 25, 2024 02:22AM
Apr 4, 2024 03:20AM
Feb 8, 2024 04:22AM Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
Oct 30, 2023 03:37AM
Jul 18, 2023 04:39AM
Apr 27, 2023 02:30AM
Mar 30, 2023 03:58AM
Feb 8, 2023 04:21AM
Oct 27, 2022 03:46AM
Jul 19, 2022 05:35AM Sobi publishes Q2 2022 report
Apr 28, 2022 05:31AM
Feb 18, 2021 02:50AM
Oct 22, 2020 02:40AM
Feb 13, 2020 02:18AM
Oct 31, 2019 03:22AM
Jul 17, 2019 02:11AM
Jun 12, 2019 07:10AM Sobi Acquires Emapalumab and Related Assets
Apr 25, 2019 02:18AM
Jan 24, 2019 02:14AM
Nov 13, 2018 02:22AM
Oct 31, 2018 03:12AM
Feb 28, 2018 08:36AM
Feb 26, 2018 02:30AM
Jun 5, 2017 09:58AM Sobi™ Keeps the Partner Products Business Area as an Integral Part of the Company

1,220,030 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All